3/11
08:10 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $15.00 price target on the stock.
High
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $15.00 price target on the stock.
3/10
02:43 pm
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was given a new $19.00 price target on by analysts at JMP Securities.
Low
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was given a new $19.00 price target on by analysts at JMP Securities.
3/7
04:05 pm
ocul
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/6
11:17 am
ocul
https://seekingalpha.com/article/4765289-ocular-therapeutix-axpaxlis-dual-trial-strategy-and-blockbuster-potential [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4765289-ocular-therapeutix-axpaxlis-dual-trial-strategy-and-blockbuster-potential [Seeking Alpha]
3/4
08:03 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
3/3
10:19 am
ocul
Ocular Therapeutix outlines AXPAXLI NDA submission timeline with SOL-1 topline data expected Q1 2026 [Seeking Alpha]
Medium
Report
Ocular Therapeutix outlines AXPAXLI NDA submission timeline with SOL-1 topline data expected Q1 2026 [Seeking Alpha]
3/3
07:07 am
ocul
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights [Yahoo! Finance]
High
Report
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights [Yahoo! Finance]
3/3
07:00 am
ocul
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
High
Report
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
2/28
07:07 pm
ocul
Ocular Therapeutix Inc (OCUL) Q4 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
High
Report
Ocular Therapeutix Inc (OCUL) Q4 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/25
08:04 am
ocul
Ocular Therapeutix™ to Present at Two Investor Conferences in March [Yahoo! Finance]
Medium
Report
Ocular Therapeutix™ to Present at Two Investor Conferences in March [Yahoo! Finance]
2/25
07:00 am
ocul
Ocular Therapeutix™ to Present at Two Investor Conferences in March
Medium
Report
Ocular Therapeutix™ to Present at Two Investor Conferences in March
2/24
08:04 am
ocul
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025 [Yahoo! Finance]
Medium
Report
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025 [Yahoo! Finance]
2/24
07:00 am
ocul
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
Medium
Report
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
2/3
08:13 am
ocul
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting [Yahoo! Finance]
Medium
Report
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting [Yahoo! Finance]
2/3
07:00 am
ocul
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
Medium
Report
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
1/17
07:00 am
ocul
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1/14
07:38 am
ocul
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR [Yahoo! Finance]
Medium
Report
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR [Yahoo! Finance]
1/14
07:00 am
ocul
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
High
Report
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
1/8
07:00 am
ocul
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
Medium
Report
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
12/19
10:02 am
ocul
Investors might be losing patience for Ocular Therapeutix's (NASDAQ:OCUL) increasing losses, as stock sheds 12% over the past week [Yahoo! Finance]
Low
Report
Investors might be losing patience for Ocular Therapeutix's (NASDAQ:OCUL) increasing losses, as stock sheds 12% over the past week [Yahoo! Finance]
12/13
07:00 am
ocul
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)